Mark A Marzinke

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Topics

Men Who Have Sex With Men

Pulmonary Tuberculosis

Human Immunodeficiency Virus

Top Venues

Antimicrobial agents and chemotherapy

Journal of the International AIDS Society

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley, Ariane van der Straten, Amanda Brown, May Beamer, Jennifer Robinson, Cindy E Jacobson, Rachel Scheckter, Katherine Bunge, Jill Schwartz, Andrea Thurman, Jeanna M Piper, Mark A Marzinke, null null
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States. Journal of the International AIDS Society 27 (3) (2024)
Kelong Han, Parul Patel, Scott McCallister, Alex R Rinehart, Yash Gandhi, William Spreen, Raphael J Landovitz, Sinead Delany-Moretlwe, Mark A Marzinke, Todd McKeon, Piotr Budnik, Jean van Wyk, Susan L Ford
Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP. Antimicrobial agents and chemotherapy (2024)
Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley, Ariane van der Straten, Amanda Brown, May Beamer, Jennifer Robinson, Cindy E Jacobson, Rachel Scheckter, Katherine Bunge, Jill Schwartz, Andrea Thurman, Jeanna M Piper, Mark A Marzinke, null null
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States. Journal of the International AIDS Society 27 (3) (2024)
Mark A Marzinke, Kelong Han, Brett Hanscom, Xu Guo, Estelle Piwowar-Manning, Craig W Hendrix, Scott Rose, Elizabeth Spooner, Carrie Mathew, Steven Innes, Rogers Sekabira, Mercy Mutambanengwe, James F Rooney, Alex R Rinehart, Adeola Adeyeye, Myron S Cohen, Mina Hosseinipour, Susan L Ford, Sinead Delany-Moretlwe
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084. Antimicrobial agents and chemotherapy (2024)
Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley, Ariane van der Straten, Amanda Brown, May Beamer, Jennifer Robinson, Cindy E Jacobson, Rachel Scheckter, Katherine Bunge, Jill Schwartz, Andrea Thurman, Jeanna M Piper, Mark A Marzinke, null null
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States. Journal of the International AIDS Society 27 (3) (2024)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Mark A Marzinke, Jessica M Fogel, Zhe Wang, Estelle Piwowar-Manning, Ryan Kofron, Amber Moser, Pradip Bhandari, Ryann Gollings, Lane R Bushman, Lei Weng, Elias K Halvas, John W Mellors, Peter L Anderson, Deborah Persaud, Craig W Hendrix, Marybeth McCauley, Alex R Rinehart, Marty St Clair, Susan L Ford, James F Rooney, Adeola Adeyeye, Suwat Chariyalertsak, Kenneth H Mayer, Roberto C Arduino, Myron S Cohen, Beatriz Gilda Jegerhorn Grinsztejn, Brett Hanscom, Raphael J Landovitz, Susan H Eshleman
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial agents and chemotherapy (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy (2023)
Ryan T Jarrett, Yuri van der Heijden, Matthew S Shotwell, Violet Chihota, Mark A Marzinke, Richard E Chaisson, Kelly E Dooley, Gavin J Churchyard
High Isoniazid Exposures When Administered with Rifapentine Once Weekly for Latent Tuberculosis in Individuals with Human Immunodeficiency Virus. Antimicrobial agents and chemotherapy 67 (2) (2023)
Mark A Marzinke, Dina N Greene, Patrick M M Bossuyt, Allison B Chambliss, Lauren R Cirrincione, Christopher R McCudden, Stacy E F Melanson, Jaime H Noguez, Khushbu Patel, Asa E Radix, Yemisi Takwoingi, Gabrielle Winston-McPherson, Bessie A Young, Melanie P Hoenig
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review. Clinical chemistry 68 (4) (2022)
Yifan Yu, Kristin L Bigos, Mark A Marzinke, Raphael J Landovitz, Marybeth McCauley, Susan Ford, Craig W Hendrix, Robert R Bies, Ethel D Weld, null null
A population pharmacokinetic model based on HPTN 077 of long-acting injectable cabotegravir for HIV PrEP. British journal of clinical pharmacology 88 (10) (2022)
Asama Tanaudommongkon, Ayyappa Chaturvedula, Craig W Hendrix, Edward J Fuchs, Eugenie Shieh, Rahul P Bakshi, Mark A Marzinke
Population pharmacokinetics of tenofovir, emtricitabine and intracellular metabolites in transgender women. British journal of clinical pharmacology 88 (8) (2022)
Ken Ho, Clara Dominguez-Islas, Daniel Szydlo, Stacey Edick, Nicole Macagna, Sharon A Riddler, Rhonda M Brand, Cindy E Jacobson, Lindsay Kramzer, Ratiya P Kunjara Na Ayudhya, Jeanna Piper, Mark A Marzinke, Jose Bauermeister, Jeremy Nuttall, Sharon L Hillier, Craig W Hendrix
MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel. Antimicrobial agents and chemotherapy 66 (11) (2022)
Teresa L Parsons, Kevin N Gwenden, Mark A Marzinke
Interspecies Differences in Tenofovir Alafenamide Fumarate Stability in Plasma. Antimicrobial agents and chemotherapy 64 (9) (2020)
Dalin Rifat, Brendan Prideaux, Radojka M Savic, Michael E Urbanowski, Teresa L Parsons, Brian M Luna, Mark A Marzinke, Alvaro A Ordonez, Vincent P DeMarco, Sanjay K Jain, Veronique Anne Dartois, William R Bishai, Kelly E Dooley
Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data. Science translational medicine 10 (435) (2019)
Kathleen Listiak Vincent, John A Moss, Mark A Marzinke, Craig W Hendrix, Peter A Anton, Richard B Pyles, Kate M Guthrie, Lauren Dawson, Trevelyn J Olive, Irina Butkyavichene, Scott A Churchman, John M Cortez, Rob Fanter, Manjula Gunawardana, Christine S Miller, Flora Yang, Rochelle K Rosen, Sara E Vargas, Marc M Baum
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial. PLoS medicine 15 (9) (2018)
Raphael J Landovitz, Sue Li, Beatriz Gilda Jegerhorn Grinsztejn, Halima Dawood, Albert Y Liu, Manya Magnus, Mina C Hosseinipour, Ravindre Panchia, Leslie Cottle, Gordon Chau, Paul Richardson, Mark A Marzinke, Craig W Hendrix, Susan H Eshleman, Yinfeng Zhang, Elizabeth Ellen Tolley, Jeremy Sugarman, Ryan Kofron, Adeola Adeyeye, David Burns, Alex R Rinehart, David Margolis, William R Spreen, Myron S Cohen, Marybeth McCauley, Joseph J Eron
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS medicine 15 (11) (2018)
Kathleen Listiak Vincent, John A Moss, Mark A Marzinke, Craig W Hendrix, Peter A Anton, Manjula Gunawardana, Lauren N Dawson, Trevelyn J Olive, Richard B Pyles, Marc M Baum
Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc. PloS one 13 (8) (2018)